A special purpose acquisition company (SPAC) sponsored by Perceptive Advisors, a leading life sciences investment firm, focused on identifying and acquiring healthcare and medical technology businesses in North America and Europe. The company leverages its management team's deep industry expertise and Perceptive Advisors' extensive network and track record to source, evaluate, and combine with target companies that possess competitive advantages, growth potential, and readiness for public markets. The SPAC provides an alternative to traditional IPOs by offering target businesses expedited access to public capital markets, enhanced liquidity, and the operational expertise of an experienced healthcare investment team.